Statins: the next step in adjuvant therapy for sepsis?

This publication has 25 references indexed in Scilit:

• Simvastatin Blunts Endotoxin-Induced Tissue Factor In Vivo
  Circulation, 2005
• Simvastatin Prevents Vascular Hyporeactivity During Inflammation
  Circulation, 2004
• HMG-CoA Reductase Inhibitor Simvastatin Profoundly Improves Survival in a Murine Model of Sepsis
  Circulation, 2004
• Evidence for anti-inflammatory activity of statins and PPARα activators in human C-reactive protein transgenic mice in vivo and in cultured human hepatocytes in vitro
  Blood, 2004
• Statins increase thrombomodulin expression and function in human endothelial cells by a nitric oxide-dependent mechanism and counteract tumor necrosis factor alpha-induced thrombomodulin downregulation
  Blood Coagulation & Fibrinolysis, 2003
• Effects of HMG-CoA Reductase Inhibitors on Coagulation and Fibrinolysis Processes
  Drugs, 2003
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
  Published by Elsevier ,2002
• Atorvastatin inhibition of cytokine‐inducible nitric oxide synthase expression in native endothelial cellsin situ
  British Journal of Pharmacology, 2002
• The Effect of Statins on Mortality in Patients with Bacteremia
  Clinical Infectious Diseases, 2001
• Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
  New England Journal of Medicine, 1998